1 document found, page 1 of 1

Sort by Issue Date

Influence of HER2 expression on prognosis in metastatic triple-negative breast ...

Gampenrieder, SP; Dezentjé, V; Lambertini, M; de Nonneville, A; Marhold, M; Le Du, F; Cortés Salgado, A; Alpuim Costa, D; Vaz Batista, M; Chic Ruché, N

Background: Triple-negative breast cancer (TNBC) is associated with poor prognosis, and new treatment options are urgently needed. About 34%-39% of primary TNBCs show a low expression of human epidermal growth factor receptor 2 (HER2-low), which is a target for new anti-HER2 drugs. However, little is known about the frequency and the prognostic value of HER2-low in metastatic TNBC. Patients and methods: We retr...

Date: 2023   |   Origin: Saúde - CUF

1 Results

Queried text

Refine Results

Author





















Date


Document Type


Access rights


Resource


Subject